Lavipharm Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	62.58	52.95	47.84	39.06	39.72
Revenue Growth (YoY)	18.20%	10.68%	22.48%	-1.68%	5.54%
Cost of Revenue	32.28	27.87	25.69	21.44	23.84
Gross Profit	30.31	25.08	22.15	17.62	15.89
Selling, General & Admin	22.99	20.9	18.11	15.31	14.48
Research & Development	0.34	0.63	0.43	0.85	0.81
Other Operating Expenses	-1.65	-1.48	-1.11	-2.4	-4.91
Operating Expenses	21.68	20.05	17.43	13.56	11.38
Operating Income	8.62	5.03	4.72	4.07	4.51
Interest Expense	-1.84	-2.01	-2.17	-0.72	-1.83
Interest & Investment Income	0.06	0.15	0.27	0.03	0.02
Currency Exchange Gain (Loss)	-0.11	-0.01	0.05	-0.02	0
Other Non Operating Income (Expenses)	-0.06	-0.07	-0.06	-0.92	-
EBT Excluding Unusual Items	6.67	3.09	2.81	2.44	2.7
Gain (Loss) on Sale of Investments	-	-	-0.48	-	-0.02
Gain (Loss) on Sale of Assets	0.79	0.36	0.43	-	-
Asset Writedown	0.04	0.16	0.37	-	0.11
Other Unusual Items	-	-	0.09	-0.18	-0.05
Pretax Income	7.5	3.6	3.22	2.26	2.75
Income Tax Expense	2.45	-5.06	1.25	1.31	1.02
Earnings From Continuing Operations	5.05	8.66	1.97	0.95	1.73
Earnings From Discontinued Operations	0.94	0.32	-0.1	-0.12	-
Net Income to Company	5.99	8.98	1.87	0.83	1.73
Minority Interest in Earnings	-0	0	0	0	-0.01
Net Income	5.99	8.98	1.87	0.83	1.72
Net Income to Common	5.99	8.98	1.87	0.83	1.72
Net Income Growth	-33.36%	380.06%	124.34%	-51.60%	-17.72%
Shares Outstanding (Basic)	168	168	168	22	17
Shares Outstanding (Diluted)	168	168	168	22	17
Shares Change (YoY)	-0.06%	0.17%	681.40%	26.42%	-
EPS (Basic)	0.04	0.05	0.01	0.04	0.10
EPS (Diluted)	0.03	0.05	0.01	0.04	0.10
EPS Growth	-34.71%	379.94%	-71.35%	-61.71%	-17.72%
Free Cash Flow	5.39	-5.15	-3.77	-32.27	2.19
Free Cash Flow Per Share	0.03	-0.03	-0.02	-1.50	0.13
Dividend Per Share	-	0.020	-	-	-
Gross Margin	48.43%	47.37%	46.30%	45.12%	40.00%
Operating Margin	13.78%	9.50%	9.86%	10.41%	11.35%
Profit Margin	9.56%	16.96%	3.91%	2.14%	4.34%
Free Cash Flow Margin	8.62%	-9.72%	-7.87%	-82.63%	5.52%
EBITDA	12.92	8.86	8.27	4.96	5.36
EBITDA Margin	20.64%	16.74%	17.30%	12.69%	13.48%
D&A For EBITDA	4.29	3.83	3.56	0.89	0.85
EBIT	8.62	5.03	4.72	4.07	4.51
EBIT Margin	13.78%	9.50%	9.86%	10.41%	11.35%
Effective Tax Rate	32.69%	-	38.78%	57.95%	37.09%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.